Department of Microbiology, Moyne Institute of Preventive Medicine, Trinity College, Dublin 2, Ireland1
Albert B. Alkek Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA2
Author for correspondence: Timothy J. Foster. Tel: +353 1 6082014. Fax: +353 1 6799294. e-mail: tfoster{at}tcd.ie
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Keywords: Staphylococcus aureus, clumping factor, collagen-binding protein, dipeptide repeat, fibrinogen-binding protein
a Present address: SmithKline Beecham, 21250 South Collegeville Road, PO Box 5089, Collegeville, PA 19426-0989, USA.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
S. aureus strains express surface receptors designated MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) that interact with proteins in the extracellular matrix such as fibrinogen (McDevitt et al., 1994 ; Ní Eidhin et al., 1998
), collagen (Switalski et al., 1989
), fibronectin (Signäs et al., 1989
), vitronectin (Liang et al., 1995
) and elastin (Park et al., 1991
). Some MSCRAMM proteins exhibit characteristics of a family of cell-wall-associated proteins with (i) a putative secretory signal sequence at the N-terminus and (ii) signals at the C-terminus that are required for anchoring the protein to the cell wall, including an LPXTG motif which is required for accurate sorting and correct orientation in the cell wall, a hydrophobic membrane-spanning region and a positively charged C-terminus that is thought to act as a signal to stop secretion. Following cleavage between the T and G of LPXTG by a novel transpeptidase (sortase), the carboxyl end of threonine is amide-linked to a free amino group of the peptidoglycan, covalently linking the protein to the cell wall (Schneewind et al., 1995
). Recently, three new proteins have been identified in S. aureus with features characteristic of cell-wall-associated proteins (Josefsson et al., 1998
). The Sdr proteins have an additional 110113-residue sequence B repeated two to five times located between the putative ligand-binding A domain and the Ser-Asp repeat region R. A dimer of the SdrB domain is quite similar to the B repeat of Cna (Josefsson et al., 1998
).
The ligand-binding activities of the clumping factors ClfA and ClfB and the collagen-binding proteins (Cna) are located in their N-terminal A domains (McDevitt et al., 1995 ; Patti et al., 1995
; Ní Eidhin et al., 1998
). In ClfA, a 308-residue dipeptide repeat composed mainly of serine and aspartate residues separates region A from the 31-residue region W. In Cna, a 187-residue B domain separates the ligand-binding A region from the 61-residue region W (Patti et al., 1992
). In the fibronectin-binding proteins (FnBPA and FnBPB) the ligand-binding domain is located in the C-terminal D repeats. In FnBP, the 92 C-terminal residue proline-rich region W is sufficient for efficient display of a lipase enzyme in a chimeric lipaseFnBP protein on the surface of Staphylococcus carnosus (Strauss & Götz, 1996
) and presumably for fibronectin binding in the native protein. In ClfA, more than 72 residues are required to link region A and the LPDTG motif in order to display the fibrinogen-binding domain on the S. aureus cell surface (Hartford et al., 1997
).
All characterized Cna+ proteins carry one, two, three or four copies of the 187-residue region B (Gillaspy et al., 1997 ; Switalski et al., 1993
), the function of which is unknown. Given the interest in using the anchoring mechanisms of surface proteins to display antigens on the surface of Gram-positive cocci (St
hl & Uhlén, 1997
) we constructed chimeric ClfACna proteins to determine if the C-terminal sequences of Cna or ClfA could support functional surface expression of another ligand-binding activity. In addition, we constructed mutants of Cna in order to determine the role of the B region in surface expression of collagen-binding activity.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Transformation and transduction.
E. coli XL-1 Blue cells were made competent by CaCl2 treatment (Sambrook et al., 1989 ). Recombinant plasmids were introduced into S. aureus by electroporation (Oskouian & Stewart, 1990
). Chimeric shuttle plasmids were transduced from S. aureus RN4220 to DU5941 using phage 85 (Foster, 1998
).
Manipulation of DNA.
DNA manipulations were performed by standard procedures (Sambrook et al., 1989 ). Chromosomal DNA of S. aureus strains was prepared by the method of Lindberg et al. (1972
). Plasmid DNA for cloning and sequence analysis was purified by WizardPlus Minipreps (Promega) followed by phenol and chloroform extraction. DNA modification enzymes were purchased from New England BioLabs or Boehringer Mannheim.
PCR amplification of clfA and cna gene fragments.
Oligonucleotide primers are listed in Table 2. Restriction sites were incorporated at the 5' end of each primer to facilitate cloning of PCR products. For amplification of clfA gene fragments, plasmid pCF3 (McDevitt et al., 1994
) was used as a template unless otherwise stated. For amplification of cna gene fragments, S. aureus strain FDA574 was used as template. The PCR reaction mixtures with Vent polymerase (New England BioLabs) were as previously described (Hartford et al., 1997
). All reactions were carried out with a 1 min denaturation step at 94 °C, a 1 min annealing step at 5058 °C depending on the primer pair, and elongation for 12 min at 72 °C depending on the length of fragment to be amplified. This standard cycle was repeated 30 times and was followed by incubation at 72 °C for 10 min. Amplified DNA was purified with Wizard PCR Preps (Promega), cleaved with restriction enzymes and ligated with vector cut with the appropriate enzymes.
|
|
Construction of a chimeric cnaclfA gene.
A cnaclfA derivative was generated by PCR amplifying the N-terminal coding regions of Cna (signal sequence and region A) using primers F1 and R1 and fusing to the PCR amplified C-terminal coding sequences of ClfA (region R, the LPDTG motif and transmembrane-spanning region of ClfA) using the primer pair F3 (incorporating a BamHI site) and R3 (incorporating a HindIII site) to generate pCN4 (Fig. 1f).
SDS-PAGE, Western immunoblotting and Western affinity blotting.
Preparation of cell-wall proteins from stabilized protoplasts by lysostaphin treatment was performed as previously described (Hartford et al., 1997 ). SDS-PAGE was performed by standard methods (Laemmli, 1970
) through a 4·5% stacking gel and a 7·5% or 10% polyacrylamide separating gel. Proteins were transferred electrophoretically to PVDF (Boehringer Mannheim) by the semi-dry system (Bio-Rad) in Tris/HCl (48 mM), glycine (39 mM) and methanol (20%). Membranes were incubated for 15 h at 4 °C in blocking reagent (Boehringer Mannheim). Polyclonal rabbit anti-ClfA region A antiserum raised against the purified recombinant fibrinogen-binding ClfA truncate (residues 220559) was used at a dilution of 1:500 and protein A conjugated to horseradish peroxidase (Sigma) was used to detect ClfA proteins using chemiluminescence (Boehringer Mannheim). Polyclonal rabbit anti-Cna region A antiserum was used at a dilution of 1:1000. For detection of fibrinogen-binding proteins by affinity blotting, purified recombinant ClfA and ClfACna proteins were fractionated by SDS-PAGE, transferred to PVDF and incubated with fibrinogen conjugated to horseradish peroxidase and detected by chemiluminescence (Boehringer Mannheim).
Measurement of cell clumping.
S. aureus strains to be tested for clumping were grown statically for 5 h in MuellerHinton broth, harvested by centrifugation at 3000 g for 10 min and washed in PBS. A suspension of 4x108 c.f.u. in a 20 µl volume was added to 50 µl of doubling dilutions of fibrinogen (starting at 1 mg ml-1, Kabi) in a microtitre plate. The highest dilution of fibrinogen promoting visible clumping of the bacterial suspension after 5 min was defined as the titre.
Adherence of bacterial cells to immobilized fibrinogen and collagen.
The assay for bacterial adherence to immobilized fibrinogen was performed as previously described (Hartford et al., 1997 ). The same procedure was used for measuring adherence to collagen using type II collagen (Sigma). Strains to be tested for adherence to collagen were grown for 15 h at 37 °C in 100 ml TSB in a 250 ml flask at 200 r.p.m.
Bacterial cell immunoblots.
Late-exponential-phase cells (OD600 0·70·8) were harvested by centrifugation and washed twice in PBS buffer. The suspensions (10 µl) and twofold dilutions were placed onto nitrocellulose membranes and allowed to dry for 15 min. Membranes were placed in blocking buffer (5% skim milk in PBS) and developed by standard immunoblotting procedures described above.
Expression of ClfA and ClfACna in E. coli.
Fragments of the clfA gene were amplified by PCR and cloned into plasmid pQE30. A 1233 bp fragment encoding the C-terminal part of region A of ClfA plus 72 residues from region R (residues 220631) was amplified using primers ClfAF1 (incorporating a BamHI site) and ClfAR1 (incorporating a HindIII site) to generate pClfA, which expressed a fusion protein with a short N-terminal segment containing six histidine residues (which allow purification by Ni2+-chelating chromatography). Fragments of the clfAcna fusion gene were amplified from pCF72 using primers ClfAF1 (incorporating a BamHI site) and CnaR1 (incorporating a HindIII site) and cloned into pQE30 to generate pClfACna, expressing a hybrid ClfACna protein with a single B domain. Expression and purification of proteins with N-terminal His-tags was performed as described by OConnell et al. (1998 ).
ELISA-type assay for fibrinogen-binding activity.
Purified recombinant ClfA and ClfACna proteins were analysed by ELISA to detect fibrinogen-binding activity. Briefly, wells in microtitre plates (Sarstedt) were coated with fibrinogen (5 µg ml-1, Kabi Pharmacia/Chromogenix) in sodium carbonate buffer [15 mM Na2HCO3, 35 mM NaH(CO3)2, 3·2 mM NaN3, pH 9·6] for 15 h at 4 °C. The plates were washed with PBS and 0·05% Tween-20 (PBS-T) and blocked with 2·5% bovine serum albumin supplemented with 0·05% Tween-20 in PBS, at 37 °C for 1 h. Following washing, purified recombinant protein in PBS was added and plates were incubated for 2 h at 37 °C. The wells were washed with PBS-T and monoclonal antibody raised against Clf41 (221-559) was added for 1 h at 37 °C. Following further washing with PBS-T, rabbit anti-mouse IgG conjugated to horseradish peroxidase (1:1000) was added for 1 h at 37 °C and developed with 100 µl of chromogenic substrate (580 µg tetramethylbenzidine ml-1, 0·0001% H2O2 in 0·1 M sodium acetate buffer, pH 5·0) for 10 min. The reaction was stopped by the addition of 50 µl 2 M H2SO4 and the A450 was measured in an ELISA plate reader (Lab Systems Multiskan Plus).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Adherence of S. aureus cna mutants to immobilized collagen
S. aureus strains carrying plasmids with cna mutations were tested for their ability to adhere to immobilized collagen (Fig. 3). DU5941(pCN1) and DU5941(pCN2), expressing Cna with two or one B repeats respectively, adhered to immobilized collagen at levels similar to the control strain Phillips, as did cells expressing Cna with no B repeat (pCN3). Adherence of bacteria expressing the CnaClfA fusion protein (pCN4) was approximately 1·6-fold lower than that of the Cna derivatives. Thus the B repeats of Cna are not required for expression of collagen-binding activity and the DS repeats of region R of ClfA can display the collagen-binding A domain of Cna in a functional form on the cell surface.
|
|
Binding of ClfACna derivatives to immobilized fibrinogen
Bacteria expressing the hybrid ClfACna protein were tested for binding to immobilized fibrinogen. As previously observed, pCF77, which expresses an engineered copy of the clfA gene, promoted adherence to immobilized fibrinogen (Hartford et al., 1997 ). In contrast, no adherence to fibrinogen was observed with bacteria expressing ClfA fused to the B domain of Cna (pCF72) (data not shown).
To measure the level of surface expression of the ClfACna chimeric proteins relative to ClfA, whole-cell dot immunoblotting was performed with exponential-phase bacterial cells and anti-ClfA serum. ClfA derivatives carrying pCF77 bound the antibody at a twofold dilution higher than strains carrying pCF72. This slightly reduced antibody binding is not sufficient to explain the complete lack of fibrinogen binding by pCF72-carrying cells. Taken together, these results indicate that region A of ClfA is located on the cell surface in the ClfACna hybrid but region B of Cna cannot fulfil the role of region R of ClfA and results in a non-functional protein.
Fibrinogen binding of recombinant ClfACna hybrid proteins
To investigate if the B region of Cna alters the conformation of region A of ClfA so that ligand binding cannot occur, a recombinant ClfACna fusion protein was expressed in E. coli and tested for its ability to bind fibrinogen by Western affinity blotting and by an ELISA-type assay. A recombinant protein expressed by pClfA comprising residues 220631 of ClfA (the ligand-binding region A residues 220559 linked to 72 residues from region R) was included as a control. Initially, Western immunoblotting of E. coli lysates was performed with anti-ClfA antibodies to confirm that each construct expressed an immunoreactive protein. Lysates of E. coli(pClfACna) induced with IPTG contained an immunoreactive protein of 58 kDa that reacted with anti-ClfA serum and bound fibrinogen in a Western affinity blot (data not shown). Plasmid pClfA expressed a fibrinogen-binding and immunoreactive protein of 46 kDa. When these recombinant proteins were analysed by ELISA, the ClfACna recombinant protein bound immobilized fibrinogen as well as the control protein, ClfA (data not shown). Thus the presence of region B of Cna does not prevent region A of ClfA from binding fibrinogen when the protein was expressed in soluble form in the cytoplasm of E. coli.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
This study shows that the 61-residue region W of Cna (plus nine additional residues) is sufficient for functional surface expression of the collagen-binding A domain in S. aureus. In ClfA, more than 72 residues (40 residues contributed by region R and 32 by region W) are required for functional expression of the fibrinogen-binding region A (Hartford et al., 1997 ). As S. aureus surface proteins are modular in composition and most likely have evolved by in vivo gene fusion events, and because of the interest in expressing antigens on the surface of Gram-positive cocci using anchoring mechanisms of surface proteins, we investigated the possibility that C-terminal sequences of Cna and ClfA could support the functional expression of heterologous ligand-binding domains. Incorporating one single 187-residue B domain plus the C-terminal anchoring signals of Cna to the ligand-binding A domain of ClfA did not promote fibrinogen binding by S. aureus cells, suggesting that the B repeat prevents correct folding of the ligand-binding domain. However, a soluble ClfACna fusion protein expressed in E. coli bound fibrinogen as well as a ClfA region A control. Thus, the B domain of Cna appears to alter the structure of the A domain of ClfA only when the hybrid protein is expressed on the bacterial cell surface.
Western immunoblotting analysis of ClfA released from S. aureus by lysostaphin treatment revealed three immunoreactive proteins, the native ClfA protein and two proteolytic breakdown products (Hartford et al., 1997 ). This implies that residues at the extreme N-terminus of ClfA are cleaved from the protein, the bulk of which, including the functional part of region A (220559), remains attached to the cell wall. A similar banding profile was observed with the ClfACna variant, confirming that ClfA region A is susceptible to proteolytic degradation. In contrast, the Cna protein migrates at its predicted molecular mass by SDS-PAGE and is not subject to proteolysis. Interestingly, a lower amount of CnaClfA protein was detected relative to the Cna B domain variants. This might explain the slightly lower collagen binding of CnaClfA-expressing bacteria compared to pCN1.
A previous study showed that when the C-terminal end of Cna is fused to protein A, the hybrid protein is targeted to the membrane and is not covalently linked to peptidoglycan by sortase (Schneewind et al., 1993 ). However, only newly synthesized proteins were analysed in these pulse-chase experiments. Proteins were considered to be membrane anchored if they were released into hot SDS after muramidase or lysostaphin treatment, whereas proteins that were covalently linked to peptidoglycan were released by lysostaphin. Here we found that much of the Cna protein is released by lysostaphin treatment, but a portion remains in the insoluble (membrane) fraction, despite repeated lysostaphin treatment (unpublished data). This suggests that sortase acts less efficiently on Cna than on other surface proteins.
In conclusion, this paper shows that the dipeptide repeat region R of ClfA is capable of supporting functional surface expression of a heterologous ligand-binding function whereas the B repeats of Cna are not. In addition, the B repeats of Cna have been shown not to be required for surface expression of collagen-binding activity by Cna.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Dr J. Patti for strain FDA574 and anti-Cna serum, Dr R. Rich for recombinant Cna B domain protein, and Dr D. OConnell and G. Mulholland for fibrinogen-conjugated horseradish peroxidase. Anti-ClfA serum and an anti-ClfA monoclonal antibody were gifts from G. Mulholland.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Duthie, E. S. & Lorenz, L. L. (1952). Staphylococcal coagulase: mode of action and antigenicity. J Gen Microbiol 6, 95-107.
Foster, T. J. (1998). Molecular genetic analysis of staphylococcal virulence. Methods Microbiol 27, 433-454.
Gillaspy, A. F., Patti, J. M., Pratt, F. L., Iandolo, J. J. & Smeltzer, M. S. (1997). The Staphylococcus aureus collagen adhesin-encoding gene (cna) is within a discrete genetic element. Gene 196, 239-248.[Medline]
Gillaspy, A. F., Lee, C. Y., Sau, S., Cheung, A. L. & Smeltzer, M. S. (1998). Factors affecting the collagen binding capacity of Staphylococcus aureus. Infect Immun 66, 3170-3178.
Hartford, O., Francois, P., Vaudaux, P. & Foster, T. J. (1997). The dipeptide repeat region of the fibrinogen-binding protein (clumping factor) is required for functional expression of the fibrinogen-binding domain on the Staphylococcus aureus cell surface. Mol Microbiol 25, 1065-1076.[Medline]
Josefsson, E., McCrea, K. W., Ní Eidhin, D., OConnell, D., Cox, J., Höök, M. & Foster, T. J. (1998). Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology 144, 3387-3395.[Abstract]
Kreiswirth, B. N., Löfdahl, M. S., Betley, M. J., OReilly, M., Schlievert, P. M., Bergdoll, M. S. & Novick, R. P. (1983). The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305, 709-712.[Medline]
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.[Medline]
Liang, O. D., Flock, J. I. & Wadström, T. (1995). Isolation and characterization of a vitronectin-binding surface protein from Staphylococcus aureus. Biochim Biophys Acta 1250, 110-116.[Medline]
Lindberg, M., Sjöstrom, J. E. & Johansson, T. (1972). Transformation of chromosomal and plasmid characters in Staphylococcus aureus. J Bacteriol 109, 844-847.[Medline]
McDevitt, D., Francois, P., Vaudaux, P. & Foster, T. J. (1994). Molecular characterization of the fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol 11, 237-248.[Medline]
McDevitt, D., Francois, P., Vaudaux, P. & Foster, T. J. (1995). Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol 16, 895-907.[Medline]
Ní Eidhin, D., Perkins, S., Francois, P., Vaudaux, P., Höök, M. & Foster, T. J. (1998). Clumping factor (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol 30, 245-257.[Medline]
Nilsson, M., Frykberg, L., Flock, J. I., Pei, L., Lindberg, M. & Guss, B. (1998). A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun 66, 2666-2673.
Miller, J. H. (1972). Experiments in Molecular Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
OConnell, D. P., Nanavaty, T., McDevitt, D., Gurusiddappa, S., Höök, M. & Foster, T. J. (1998). The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site. J Biol Chem 273, 6821-6829.
Oskouian, B. & Stewart, G. C. (1990). Repression and catabolite repression of the lactose operon of Staphylococcus aureus. J Bacteriol 172, 3804-3812.[Medline]
Park, P. W., Roberts, D. D., Grosso, L. E., Parks, W. C., Rosenbloom, J., Abrams, W. R. & Mecham, R. P. (1991). Binding of elastin to Staphylococcus aureus. J Biol Chem 266, 23399-23406.
Patti, J. M., Jönsson, H., Guss, B., Switalski, L. M., Wiberg, K., Lindberg, M. & Höök, M. (1992). Molecular characterisation and expression of a gene encoding a Staphylococcus aureus collagen adhesin. J Biol Chem 267, 4766-4772.
Patti, J. M., House-Pompeo, K., Boles, J. O., Garza, N., Gurusiddappa, S. & Höök, M. (1995). Critical residues in the ligand-binding site of the Staphylococcus aureus collagen-binding adhesin (MSCRAMM). J Biol Chem 270, 12005-12011.
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
Schneewind, O., Mihaylova-Petkov, D. & Model, P. (1993). Cell wall sorting signals in surface proteins of gram-positive bacteria. EMBO J 12, 4803-4811.[Abstract]
Schneewind, O., Fowler, A. & Faull, K. F. (1995). Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science 268, 103-106.[Medline]
Signäs, C., Raucci, G., Jönsson, K., Lindgren, P. E., Anantharamaiah, G. M., Höök, M. & Lindberg, M. (1989). Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Natl Acad Sci USA 86, 699-703.[Abstract]
Sthl, S. & Uhlén, M. (1997). Bacterial surface display: trends and progress. Trends Biotechnol 15, 185-192.[Medline]
Strauss, A. & Götz, F. (1996). In vivo immobilization of enzymatically active polypeptides on the cell surface of Staphylococcus carnosus. Mol Microbiol 21, 491-500.[Medline]
Switalski, L. M., Speziale, P. & Höök, M. (1989). Isolation and characterization of a putative collagen receptor from Staphylococcus aureus strain Cowan 1. J Biol Chem 264, 21080-21086.
Switalski, L. M., Patti, J. M., Butcher, W., Gristina, A. G., Speziale, P. & Höök, M. (1993). A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol Microbiol 7, 99-107.[Medline]
Vaudaux, P. E., Francois, P., Proctor, R. A., McDevitt, D., Foster, T. J., Albrecht, R. M., Lew, D. P., Wabers, H. & Cooper, S. L. (1995). Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arterio-venous shunts. Infect Immun 63, 585-590.[Abstract]
Waldvogel, F. A. (1995). Staphylococcus aureus (including toxic shock syndrome). In Principles and Practice of Infectious Diseases, pp. 1754-1777. Edited by G. L. Mandel, J. E. Bennett & R. Dolin. New York: Churchill Livingstone.
Wann, E. R., Dassy, B., Fournier, J.-M. & Foster, T. J. (1999). Genetic analysis of the cap5 locus of Staphylococcus aureus. FEMS Microbiol Lett 170, 97-103.[Medline]
Watson, D. L. (1989). Expression of a pseudocapsule by Staphylococcus aureus: influence of cultural conditions and relevance to mastitis. Res Vet Sci 47, 152-157.[Medline]
Received 1 March 1999;
revised 6 May 1999;
accepted 25 May 1999.